Eli Lilly and Company (LLY) will begin trading ex-dividend on August 13, 2020. A cash dividend payment of $0.74 per share is scheduled to be paid on September 10, 2020. Shareholders who purchased LLY prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that LLY has paid the same dividend. At the current stock price of $150.63, the dividend yield is 1.97%.
The previous trading day's last sale of LLY was $150.63, representing a -11.78% decrease from the 52 week high of $170.75 and a 48.61% increase over the 52 week low of $101.36.
LLY is a part of the Health Care sector, which includes companies such as Johnson & Johnson (JNJ) and Pfizer, Inc. (PFE). LLY's current earnings per share, an indicator of a company's profitability, is $6.16. Zacks Investment Research reports LLY's forecasted earnings growth in 2020 as 20.92%, compared to an industry average of 8.3%.
Interested in gaining exposure to LLY through an Exchange Traded Fund [ETF]?
The following ETF(s) have LLY as a top-10 holding:
- VanEck Vectors Pharmaceutical ETF (PPH)
- Invesco Dynamic Pharmaceuticals ETF (PJP)
- iShares U.S. ETF Trust (IEIH)
- SPDR S&P Pharmaceuticals ETF (XPH)
- iShares U.S. Pharmaceutical ETF (IHE).
The top-performing ETF of this group is XPH with an increase of 32.65% over the last 100 days. PPH has the highest percent weighting of LLY at 5.01%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.